ArticleTherapeutic advances in medical oncology2025

Trastuzumab-deruxtecan shows interesting disease control in a multitreated patient with ERBB2 amplified parotid carcinoma, a case report.

Camille Evrard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.